1. Home
  2. Analysis
  3. Accuneb
  4. Ibu

Accuneb and Ibu drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 6 people who take Accuneb and Ibu. Common interactions include dizziness among females, and abdominal distension among males.

The phase IV clinical study analyzes what interactions people who take Accuneb and Ibu have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 29, 2023

6 people who take Accuneb and Ibu together, and have interactions are studied.

What is Accuneb?

Accuneb has active ingredients of albuterol sulfate. Currently, eHealthMe is studying from 182 Accuneb users.

What is Ibu?

Ibu has active ingredients of ibuprofen. It is used in pain. Currently, eHealthMe is studying from 232,440 Ibu users.

Number of Accuneb and Ibu reports submitted per year:

Accuneb and Ibu drug interactions.

Common Accuneb and Ibu drug interactions by gender *:

female:

  1. Dizziness
  2. Metastases to peritoneum
  3. Neuroendocrine carcinoma metastatic
  4. Neuroendocrine tumour
  5. Tardive dyskinesia
  6. Vision blurred

male:

  1. Abdominal distension
  2. Abdominal pain
  3. Ileus
  4. Lymphadenopathy mediastinal
  5. Pneumonia
  6. Pyrexia
  7. Rectal haemorrhage
  8. Seizure
  9. Thoracic vertebral fracture
  10. Abdominal pain lower

Common Accuneb and Ibu drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Abdominal distension
  2. Abdominal pain
  3. Abdominal pain lower
  4. Constipation
  5. Faeces hard
  6. Haematochezia
  7. Rectal haemorrhage

40-49:

n/a

50-59:

n/a

60+:

  1. Bone loss
  2. Disease progression
  3. Vision blurred
  4. Dizziness
  5. Hilar lymphadenopathy
  6. Lymphadenopathy mediastinal
  7. Metastases to peritoneum
  8. Neuroendocrine carcinoma metastatic
  9. Neuroendocrine tumour
  10. Tardive dyskinesia

* Approximation only. Some reports may have incomplete information.

Do you take Accuneb and Ibu?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

Drug side effects by duration, gender and age:

Browse interactions between Accuneb and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Ibu drug interactions:

Browse interactions between Ibu and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on albuterol sulfate and ibuprofen (the active ingredients of Accuneb and Ibu, respectively), and Accuneb and Ibu (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Accuneb and Ibu.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.